Cancer Research UK logo.
SearchDonate
  • Search

A study looking at pembrolizumab for bladder cancer (KEYNOTE-057)

Overview

Cancer types:

Bladder cancer

Status:

Closed

Phase:

Phase 2

Details

This study is for people with early (non muscle invasive) bladder cancer, who have had BCG treatment that was not successful. They must also be at high risk of their cancer coming back or spreading into the deeper layers of the bladder.

Recruitment start: 16 December 2016

Recruitment end: 30 November 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Mr Jeremy Crew

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 22 January 2019

CRUK internal database number: 14791

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.